Health Care in America: Profit-Driven For Somebody, Invariably A Consummate Douchebag
$13.50 a pill to $750 - an increase of 5,455 % - thus proving once and for all why health care should not be a for-profit business. The
toxoplasmosis, an opportunistic parasitic infection that strikes people with compromised immune systems. The drug, which sold for slightly over $1 a tablet a few years ago, has been passed from one pharmaceutical company to the other in recent years.
All water off the back of a clueless narcissistDespite the blowback to his latest travesty, really doesn’t make sense to get any criticism for this.” He argues the drug was formerly unprofitable, it's still "under-priced," it will now fetch a "reasonable profit," and because he's such a good guy he will use the money it earns at $750 a pop to develop better treatments. “This isn’t the greedy drug company trying to gouge patients," he says. "It is us trying to stay in business."
Doctors are calling HIV Medicine Association have sent a joint letter calling the price increase for Daraprim “unjustifiable for the medically vulnerable patient population” and “unsustainable for the health care system.” Meanwhile, regular folks, both ill and well, have decided "Martin Shkreli deserves a special place in hell." He is "a greedy creep in a suit...a vermin...a sociopath...a turd with feet." "Like, holy shit. I want him invited to every AIDS related funeral." "This guy is pure evil. A living piece of human garbage. (He) deserves to die of a rare disease that has a cure, but the medicine is too expensive for him to purchase. He deserves to beg and plead for the cure he can't afford, and to be ignored as his life slowly slips away.""This little punk (with his) heinous level of greed rarely seen in such open display (has) destroyed much and hurt many." And from a petition, "Take this guy down." We'd add, along with the putrid system that gave rise to him.on his BS, insisting the insane price hike will doubtless hurt many suffering from a disease that in any case hasn't been "clamoring for better therapies.” The Infectious Diseases Society of America and the